| Literature DB >> 33973200 |
Shirin Moossavi1,2,3, Kelsey Fehr4,5,6, Hassan Maleki7,8, Simin Seyedpour9,10, Mahdis Keshavarz-Fathi11,12, Farhad Tabasi13,14,15, Mehrdad Heravi13,15, Rayka Sharifian16,17,18, Golnaz Shafiei19,20,21, Negin Badihian22,23, Roya Kelishadi22,23, Shahrzad Nematollahi18,16, Majid Almasi19,21, Saskia Popescu24,25, Mahsa Keshavarz-Fathi26,27, Nima Rezaei28,29,30.
Abstract
The disease 2019 (COVID-19) made a public health emergency in early 2020. Despite attempts for the development of therapeutic modalities, there is no effective treatment yet. Therefore, preventive measures in various settings could help reduce the burden of disease. In this chapter, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19, non-pharmaceutical approaches at individual and population level, chemoprevention, immunoprevention, preventive measures in different healthcare settings and other professions, special considerations in high-risk groups, and the role of organizations to hamper the psychosocial effects will be discussed.Entities:
Keywords: COVID-19; Healthcare; Nosocomial infection; Personal protective equipment; Preventive measures; Psychological effects; Vaccine
Mesh：
Substances：
Year: 2021 PMID： 33973200 DOI： 10.1007/978-3-030-63761-3_32
Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622